KCT0000933
Not yet recruiting
未知
Thrombolytic efficacy of intravenous recombinant tissue plasminogen activator with different doses
ConditionsDiseases of the nervous system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 32
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Above 20 year old
- •? Clear onset time, acute middle cerebral artery infarction patients within 3 hours after onset
- •? Above 4 of National Institute of Health Stroke Scale
- •? thin\-section noncontrast CT before and after intravenous recombinant tissue plasminogen activator
- •? patients who treated with intravenous recombinant tissue plasminogen activator
- •? agreement with this study
Exclusion Criteria
- •? contraindication of intravenous recombinant tissue plasminogen activator
- •I.Comatous mentality
- •II.rapidly improved neurologic deficit or below 4 of National Institute of Health Stroke Scale 4
- •III.Septic embolism
- •IV.Risk of bleeding: Known AV malformation of aneurysm, within 7 days of non\-compressible site arterial puncture, SAH , INR\> 1\.7, within 48 hours of heparin and aPTT \>1\.5 times the upper limit of normal
- •V.otherwise relative contraindications
- •? contraindication of CT
- •? impossible case of thin section brain CT before and after treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis.acute exacerbation of idiopathic pulmonary fibrosisJPRN-UMIN000009082Toho university10
Completed
Not Applicable
The efficacy of recombinant thrombomodulin for post transplant coagulopathy in childrechildren with coagulopathy after hematopoietic stem cell transplantationJPRN-UMIN000005117Yokohama City University Hospital50
Recruiting
Not Applicable
Effectiveness of intravenous thrombolysis in patients with mild stroke symptomsDiseases of the nervous systemKCT0000842Seoul National University Bundang Hospital1,396
Recruiting
Not Applicable
Clinical trial on efficacy for recombinant-thrombomodulin for disseminated intravascular coagulation in critical careJPRN-UMIN000006580Critical Care Medicine, Nara Hospital, Kinki University School of Medicine20
Not yet recruiting
Phase 2
The efficacy of recombinant thrombomodulin in a patient with cholangitis with DICCholangitis with DICJPRN-UMIN000018607Yokohama city university, Depertment of gastroenterologicl surgery250